Cargando…
Anticoagulation in Patients With COVID-19: JACC Review Topic of the Week
Clinical, laboratory, and autopsy findings support an association between coronavirus disease-2019 (COVID-19) and thromboembolic disease. Acute COVID-19 infection is characterized by mononuclear cell reactivity and pan-endothelialitis, contributing to a high incidence of thrombosis in large and smal...
Autores principales: | Farkouh, Michael E., Stone, Gregg W., Lala, Anuradha, Bagiella, Emilia, Moreno, Pedro R., Nadkarni, Girish N., Ben-Yehuda, Ori, Granada, Juan F., Dressler, Ovidiu, Tinuoye, Elizabeth O., Granada, Carlos, Bustamante, Jessica, Peyra, Carlos, Godoy, Lucas C., Palacios, Igor F., Fuster, Valentin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884342/ https://www.ncbi.nlm.nih.gov/pubmed/35241226 http://dx.doi.org/10.1016/j.jacc.2021.12.023 |
Ejemplares similares
-
Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized With COVID-19
por: Stone, Gregg W., et al.
Publicado: (2023) -
Fulminant Myocarditis Following SARS-CoV-2 Infection: JACC Patient Care Pathways
por: Rajpal, Saurabh, et al.
Publicado: (2022) -
Conduct of Clinical Trials in the Era of COVID-19: JACC Scientific Expert Panel
por: Psotka, Mitchell A., et al.
Publicado: (2020) -
Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art Review
por: Talasaz, Azita H., et al.
Publicado: (2021) -
Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review
por: Talasaz, Azita H., et al.
Publicado: (2021)